Itinai.com stem cells therapy chaos 50 stylize 500 weir ebdc9192 9a23 4da2 aa35 12e91fb2f4b3 1
Itinai.com stem cells therapy chaos 50 stylize 500 weir ebdc9192 9a23 4da2 aa35 12e91fb2f4b3 1

Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.

 Cancer trial: Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.

Conditions: Advanced Breast Cancer; ER-positive Breast Cancer; HER2-negative Breast Cancer; ESR1 Gene Mutation

Interventions: Drug: Everolimus; Drug: Elacestrant; Drug: Placebo; Drug: Auxiliary Medicinal Product – Dexamethasone; Drug: Auxiliary Medicinal Product – Luteinizing hormone-releasing hormone (LHRH) analogues

Sponsors: MedSIR; Stemline Therapeutics, Inc.

Not yet recruiting

AI-Powered Health Tools

Interactive AI Tools to Help You Understand Your Health

Solutions for Smart Healthcare

Clinical Research